triiodothyronine has been researched along with Substance Withdrawal Syndrome in 32 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Maternal nicotine exposure leads to neonatal hypothyroidism that can be returned to euthyroidism after nicotine withdrawal." | 7.77 | Neonatal hypothyroidism caused by maternal nicotine exposure is reversed by higher T3 transfer by milk after nicotine withdraw. ( Christian Manhães, A; Claudio-Neto, S; de Moura, EG; de Oliveira, E; Lisboa, PC; Passos, MC; Pinheiro, CR; Santos-Silva, AP, 2011) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 7.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "Blood thyroid hormone levels were measured during, and for 6 days after, treatment with propranolol (160 mg/day, 4-8 weeks) in five hyperthyroid patients and six normal volunteers." | 7.66 | The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects. ( John, R; Jones, MK; Ross, PJ, 1980) |
| "Maternal nicotine exposure leads to neonatal hypothyroidism that can be returned to euthyroidism after nicotine withdrawal." | 3.77 | Neonatal hypothyroidism caused by maternal nicotine exposure is reversed by higher T3 transfer by milk after nicotine withdraw. ( Christian Manhães, A; Claudio-Neto, S; de Moura, EG; de Oliveira, E; Lisboa, PC; Passos, MC; Pinheiro, CR; Santos-Silva, AP, 2011) |
| " Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 3.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "Spermatogenic function was studied in 10 patients, previously diagnosed as having primary hypothyroidism, in whom a state of hypothyroidism has been induced by discontinuation or a decrease in treatment with levothyroxine over at least one spermatogenic cycle." | 3.68 | Primary hypothyroidism and human spermatogenesis. ( Corrales Hernández, JJ; García Diez, LC; Miralles García, JM, 1990) |
| "The effects of maternal use of methadone during pregnancy on tests of thyroid function were studied in 14 women and their offspring." | 3.66 | Effects of methadone on thyroid function in mother, fetus, and newborn. ( Chandavasu, O; Dube, SK; Evans, HE; Glass, L; Jhaveri, RC; Khan, F; Rosenfeld, W; Salazar, JD, 1980) |
| "Blood thyroid hormone levels were measured during, and for 6 days after, treatment with propranolol (160 mg/day, 4-8 weeks) in five hyperthyroid patients and six normal volunteers." | 3.66 | The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects. ( John, R; Jones, MK; Ross, PJ, 1980) |
| "During cocaine addiction the hypothalamus-pituitary axis is widely affected and a blunted response of thyroid stimulating hormone (TSH) to thyroid releasing hormone (TRH) consistent with a hyperthyroid state has been observed." | 2.69 | Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. ( Pezzarossa, A; Vescovi, PP, 1999) |
| " Tapering propranolol dosage is frequently used in the hope of preventing adverse withdrawal events but the success of such a maneuver has not been shown." | 2.65 | Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule. ( Lutterodt, A; Nattel, S; Rangno, RE, 1982) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| " This case illustrates the potential for hypothyroid-induced renal dysfunction to lead to adverse clinical consequences in patients taking medications cleared by the kidneys." | 1.35 | Lithium toxicity precipitated by profound hypothyroidism. ( Gohh, R; Gopalakrishnan, G; Hennessey, JV; Phillips, BD, 2008) |
| "The severity of opioid abuse and of withdrawal symptoms was assessed." | 1.35 | Alterations in pituitary-thyroid axis function among opioid-dependent subjects after acute and protracted abstinence. ( Chi, Y; Du, WJ; Guo, S; Jiang, ZN; Liu, ZQ; Luo, XN; Sheng, LX; Smith, AK; Tang, YL; Xiao, L; Zhang, GF; Zhang, HX, 2009) |
| "The effect of chronic administration of morphine and subsequent withdrawal on brain and pituitary receptors for thyrotropin releasing hormone (TRH) was investigated in Sprague-Dawley rats." | 1.28 | The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats. ( Bansinath, M; Bhargava, HN; Das, S; Prasad, R, 1989) |
| "The group of patients with thyroid adenoma served as control (group I)." | 1.26 | TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy. ( Fukuda, H; Kamio, N; Kobayashi, I; Kobayashi, S; Maruta, S; Ohsawa, N; Ohshima, K; Suwa, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (50.00) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 4 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Papadakis, G | 1 |
| Kalaitzidou, S | 1 |
| Triantafillou, E | 1 |
| Drosou, A | 1 |
| Kakava, K | 1 |
| Dogkas, N | 1 |
| Pappa, T | 1 |
| Kaltzidou, V | 1 |
| Tertipi, A | 1 |
| Villiotou, V | 1 |
| Pappas, A | 1 |
| Phillips, BD | 1 |
| Gopalakrishnan, G | 1 |
| Gohh, R | 1 |
| Hennessey, JV | 1 |
| Chou, HK | 1 |
| Tsao, YT | 1 |
| Lin, SH | 1 |
| Zhang, GF | 1 |
| Tang, YL | 1 |
| Smith, AK | 1 |
| Liu, ZQ | 1 |
| Sheng, LX | 1 |
| Chi, Y | 1 |
| Du, WJ | 1 |
| Guo, S | 1 |
| Jiang, ZN | 1 |
| Xiao, L | 1 |
| Zhang, HX | 1 |
| Luo, XN | 1 |
| Brenta, G | 1 |
| Celi, FS | 1 |
| Pisarev, M | 1 |
| Schnitman, M | 1 |
| Sinay, I | 1 |
| Arias, P | 1 |
| Lee, J | 1 |
| Yun, MJ | 1 |
| Nam, KH | 1 |
| Chung, WY | 1 |
| Soh, EY | 1 |
| Park, CS | 1 |
| de Oliveira, E | 1 |
| de Moura, EG | 1 |
| Santos-Silva, AP | 1 |
| Pinheiro, CR | 1 |
| Claudio-Neto, S | 1 |
| Christian Manhães, A | 1 |
| Passos, MC | 1 |
| Lisboa, PC | 1 |
| Hermann, D | 1 |
| Heinz, A | 1 |
| Mann, K | 1 |
| SOYKA, LF | 1 |
| CRAWFORD, JD | 1 |
| Rasmussen, DD | 1 |
| Botella-Carretero, JI | 1 |
| Gómez-Bueno, M | 1 |
| Barrios, V | 1 |
| Caballero, C | 1 |
| García-Robles, R | 1 |
| Sancho, J | 1 |
| Escobar-Morreale, HF | 1 |
| Regalbuto, C | 1 |
| Alagona, C | 1 |
| Maiorana, R | 1 |
| Di Paola, R | 1 |
| Cianci, M | 1 |
| Alagona, G | 1 |
| Sapienza, S | 1 |
| Vigneri, R | 1 |
| Pezzino, V | 1 |
| Duick, DS | 1 |
| Wahner, HW | 1 |
| Edis, AJ | 1 |
| van Heerden, JA | 1 |
| Rangno, RE | 2 |
| Nattel, S | 1 |
| Lutterodt, A | 2 |
| Ohsawa, N | 1 |
| Kobayashi, I | 1 |
| Suwa, K | 1 |
| Kamio, N | 1 |
| Maruta, S | 1 |
| Ohshima, K | 1 |
| Fukuda, H | 1 |
| Kobayashi, S | 1 |
| Melander, A | 1 |
| Thorell, J | 1 |
| Wadstein, J | 1 |
| Langlois, S | 1 |
| Jhaveri, RC | 2 |
| Glass, L | 2 |
| Evans, HE | 2 |
| Dube, SK | 2 |
| Rosenfeld, W | 2 |
| Khan, F | 2 |
| Salazar, JD | 1 |
| Chandavasu, O | 1 |
| Schaeffer, HA | 1 |
| Ross, PJ | 1 |
| Jones, MK | 1 |
| John, R | 1 |
| Kaptein, EM | 1 |
| Vescovi, PP | 1 |
| Pezzarossa, A | 1 |
| Kristensen, BO | 2 |
| Steiness, E | 1 |
| Weeke, J | 1 |
| Vagenakis, AG | 1 |
| Braverman, LE | 1 |
| Azizi, F | 1 |
| Portinay, GI | 1 |
| Ingbar, SH | 1 |
| Denicoff, KD | 1 |
| Joffe, RT | 1 |
| Lakshmanan, MC | 1 |
| Robbins, J | 1 |
| Rubinow, DR | 1 |
| Corrales Hernández, JJ | 1 |
| Miralles García, JM | 1 |
| García Diez, LC | 1 |
| Bhargava, HN | 1 |
| Das, S | 1 |
| Bansinath, M | 1 |
| Prasad, R | 1 |
| English, TN | 1 |
| Ruxton, D | 1 |
| Eastman, CJ | 1 |
| Studer, H | 1 |
| Greer, MA | 1 |
| Akiba, Y | 1 |
| Itoh, H | 1 |
| Matsumoto, T | 1 |
1 review available for triiodothyronine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism.
Topics: Alcoholism; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Substance Withdrawal Syndrome; T | 2002 |
3 trials available for triiodothyronine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Hypothyroidism; Iodine Radio | 2010 |
Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Epineph | 1982 |
Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts.
Topics: Adult; Chronic Disease; Cocaine-Related Disorders; Human Growth Hormone; Humans; Male; Substance Wit | 1999 |
28 other studies available for triiodothyronine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle A | 2015 |
Lithium toxicity precipitated by profound hypothyroidism.
Topics: Bipolar Disorder; Female; Humans; Hypothyroidism; Lithium Compounds; Middle Aged; Renal Insufficienc | 2008 |
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Alterations in pituitary-thyroid axis function among opioid-dependent subjects after acute and protracted abstinence.
Topics: Adult; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Male; Narcotics; Pituitary Glan | 2009 |
Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance.
Topics: Acute Disease; Adult; Aged; Carcinoma, Medullary; Carcinoma, Papillary; Female; Glucose Tolerance Te | 2009 |
Neonatal hypothyroidism caused by maternal nicotine exposure is reversed by higher T3 transfer by milk after nicotine withdraw.
Topics: Animals; Animals, Newborn; Female; Hypothyroidism; Lactation; Maternal Exposure; Milk; Nicotine; Rat | 2011 |
ANTAGONISM BY CORTISONE OF THE LINEAR GROWTH INDUCED IN HYPOPITUITARY PATIENTS AND HYPOPHYSECTOMIZED RATS BY HUMAN GROWTH HORMONE.
Topics: Adolescent; Cortisone; Drug Therapy; Growth; Growth Hormone; Human Growth Hormone; Humans; Hypophyse | 1965 |
Chronic daily ethanol and withdrawal: 5. Diurnal effects on plasma thyroid hormone levels.
Topics: Alcoholism; Animals; Circadian Rhythm; Ethanol; Male; Rats; Rats, Sprague-Dawley; Substance Withdraw | 2003 |
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Topics: Adult; Blood Pressure; Carcinoma, Papillary, Follicular; Cardiovascular Diseases; Cell Differentiati | 2004 |
Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.
Topics: Adolescent; Adult; Attention; Blood Pressure; Cardiovascular System; Female; Heart Rate; Humans; Hyp | 2006 |
Effects of oral thyrotropin-releasing hormone, exogenous thyroid-stimulating hormone, and withdrawal of triiodothyronine on 131I uptake after subtotal thyroidectomy.
Topics: Adolescent; Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Receptors, Cell Surface; | 1980 |
TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy.
Topics: Adenoma; Female; Humans; Prolactin; Substance Withdrawal Syndrome; Thyroid Neoplasms; Thyroiditis, A | 1981 |
Alteration of thyroid hormone economy during alcohol withdrawal in alcoholics.
Topics: Alcohol Withdrawal Delirium; Alcoholism; Humans; Substance Withdrawal Syndrome; Thyroid Hormones; Th | 1982 |
Metoprolol withdrawal phenomena: mechanism and prevention.
Topics: Adult; Aged; Blood Pressure; Drug Administration Schedule; Epinephrine; Heart Rate; Humans; Isoprote | 1982 |
Effects of methadone on thyroid function in mother, fetus, and newborn.
Topics: Adolescent; Adult; Age Factors; Female; Fetal Blood; Humans; Infant, Newborn; Infant, Newborn, Disea | 1980 |
Relationship of thyroid hormone levels to the severity of the narcotic withdrawal syndrome.
Topics: Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Methadone; Pregnancy; Prospective | 1981 |
The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects.
Topics: Adult; Female; Humans; Hyperthyroidism; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrom | 1980 |
Hormone-specific alterations of T4, T3, and reverse T3 metabolism with recent ethanol abstinence in humans.
Topics: Adult; Alcoholism; Ethanol; Female; Humans; Male; Middle Aged; Models, Biological; Reference Values; | 1997 |
[Risks in sudden withdrawal of beta-blocking drugs--beta-blockade withdrawal syndrome].
Topics: Adrenergic beta-Antagonists; Humans; Risk; Substance Withdrawal Syndrome; Syndrome; Triiodothyronine | 1978 |
The pathogenesis of propranolol-withdrawal syndrome in essential hypertension.
Topics: Adult; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Substance Withdrawa | 1979 |
Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.
Topics: Adult; Aged; Female; Goiter; Humans; Middle Aged; Substance Withdrawal Syndrome; Thyroid (USP); Thyr | 1975 |
Neuropsychiatric manifestations of altered thyroid state.
Topics: Adult; Affect; Attitude to Health; Cognition; Depressive Disorder; Female; Humans; Male; Mental Diso | 1990 |
Primary hypothyroidism and human spermatogenesis.
Topics: Humans; Hypothyroidism; Male; Spermatogenesis; Substance Withdrawal Syndrome; Thyrotropin; Thyroxine | 1990 |
The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Topics: Animals; Brain; Cell Membrane; Drug Tolerance; Male; Morphine; Morphine Dependence; Naloxone; Pituit | 1989 |
Abnormalities in thyroid function associated with chronic therapy with methadone.
Topics: Adolescent; Adult; Female; Humans; Male; Methadone; Substance Withdrawal Syndrome; Thyroid Gland; Th | 1988 |
Thyroid function during the rebound phase following the discontinuation of antithyroid drugs.
Topics: Animals; Deficiency Diseases; Diiodotyrosine; Humans; Iodine; Perchlorates; Propylthiouracil; Rats; | 1967 |
Rebound phenomena in thyroid function after withdrawal of propylthiouracil in growing chicks.
Topics: Animals; Body Weight; Chickens; Diiodotyrosine; Humans; Iodides; Iodine Isotopes; Male; Monoiodotyro | 1971 |